India to Kyrgyzstan: Sofosbuvir Export Trade Route

The India to Kyrgyzstan Sofosbuvir corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $216.8K USD. The route is dominated by ROGER MEDICALS, which alone accounts for roughly 59% of all export value, reflecting the consolidated nature of India's sofosbuvir manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $108.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with sofosbuvir's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 26.7%, placing it at rank #3 among India's top sofosbuvir export destinations globally.

On the import side, key buyers of Indian sofosbuvir in Kyrgyzstan include STATE-OWNED ENTERPRISE, MS. STATE-OWNED ENTERPRISE is the single largest importer with 1 shipments valued at $128.8K USD.

India's sofosbuvir exports to Kyrgyzstan are driven primarily by a handful of large-scale manufacturers. ROGER MEDICALS with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Kyrgyzstan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ROGER MEDICALS, HETERO LABS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $108.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as lisof ledipasvir 90mg + sofosbuvir 400mg, suggesting that buyers in Kyrgyzstan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, STATE-OWNED ENTERPRISE is the largest importer with 1 shipments worth $128.8K USD — representing 59% of all sofosbuvir imports from India on this route.